Skip to Main Content

Author Details

Sarah J Lincoln
Mayo Clinic
1996
112
49
PMIDPaper TitleJournal TitlePublished Year
37327267The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer's disease: A cross-sectional study.Medicine (Baltimore)2023
35047668Clinical Deep Phenotyping of <i>ABCA7</i> Mutation Carriers.Neurol Genet2022
35388616Transcriptional landscape of human microglia implicates age, sex, and APOE-related immunometabolic pathway perturbations.Aging Cell2022
35307406Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans.EBioMedicine2022
34020725Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease.Acta Neuropathol Commun2021
33726851Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer's disease.Acta Neuropathol Commun2021
32164763Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.Acta Neuropathol Commun2020
33092647Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy.Acta Neuropathol Commun2020
32660529Deciphering cellular transcriptional alterations in Alzheimer's disease brains.Mol Neurodegener2020
32928256Correction to: Deciphering cellular transcriptional alterations in Alzheimer's disease brains.Mol Neurodegener2020
29107053Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.Alzheimers Dement2018
30078640An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor.Neurobiol Aging2018
30136084Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy.Acta Neuropathol2018
30326945ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans.Mol Neurodegener2018
27939925A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.Alzheimers Dement2017
28097223<i>ABCA7</i> loss-of-function variants, expression, and neurologic disease risk.Neurol Genet2017
27115769Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.Acta Neuropathol2016
26507310Evaluating pathogenic dementia variants in posterior cortical atrophy.Neurobiol Aging2016
27727239Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases.Sci Data2016
25886450TREM2 is associated with increased risk for Alzheimer's disease in African Americans.Mol Neurodegener2015
27066552Late-onset Alzheimer disease risk variants mark brain regulatory loci.Neurol Genet2015
25836420Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.Neurobiol Dis2015
25324900Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.Alzheimers Res Ther2014
23365052DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss.Neurology2013
23750206LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD).PLoS One2013
22154298First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation.Parkinsonism Relat Disord2012
22722634Novel late-onset Alzheimer disease loci variants associate with brain gene expression.Neurology2012
22685416Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.PLoS Genet2012
22647713LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors.Mol Neurodegener2012
21412835Common variants in PARK loci and related genes and Parkinson's disease.Mov Disord2011
21763482VPS35 mutations in Parkinson disease.Am J Hum Genet2011
21907011Translation initiator EIF4G1 mutations in familial Parkinson disease.Am J Hum Genet2011
20144646Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease.Mech Ageing Dev2010
20697047Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease.Arch Neurol2010
20669305Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.Mov Disord2010
20659558Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.Neurobiol Dis2010
19006224Genotype-phenotype correlates in Taiwanese patients with early-onset recessive Parkinsonism.Mov Disord2009
19890971Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.Mov Disord2009
19632874A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction.Parkinsonism Relat Disord2009
19590691Dopamine transporter genetic variants and pesticides in Parkinson's disease.Environ Health Perspect2009
19429005Phactr2 and Parkinson's disease.Neurosci Lett2009
19573577GCH1 expression in human cerebellum from healthy individuals is not gender dependent.Neurosci Lett2009
19085912ATP13A2 variability in Parkinson disease.Hum Mutat2009
19133659FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.Mov Disord2009
18322262Alpha-synuclein, pesticides, and Parkinson disease: a case-control study.Neurology2008
18723524Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.Hum Mol Genet2008
18976489In vivo silencing of alpha-synuclein using naked siRNA.Mol Neurodegener2008
17225181Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.Neurogenetics2007
17531291Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.Mech Ageing Dev2007
17556099Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study.Neurosci Lett2007
  • 1 - 50 of 112

Recommended Authors

Michael A Gonzalez
The Genesis Project Foundation
Career Start Year 2012
Number of shared co-authors 16
Eva C Schulte
Institute of Psychiatric Phenomics and Genomics (IPPG), LMU University Hospital
Career Start Year 2009
Number of shared co-authors 9
Olena Korvatska
University of Washington
Career Start Year 2009
Number of shared co-authors 5
Nicolas Casadei
Institute of Medical Genetics and Applied Genomics, University of Tubingen
Career Start Year 2007
Number of shared co-authors 4
Mike A Nalls
Center for Alzheimer's and Related Dementias, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 64
James M Polke
National Hospital for Neurology and Neurosurgery
Career Start Year 2005
Number of shared co-authors 8
Jana Vandrovcova
UCL Queen Square Institute of Neurology
Career Start Year 2004
Number of shared co-authors 11
Mina Ryten
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 2001
Number of shared co-authors 45
Ifat Bar-Joseph
The Center for Cancer Research-Sheba Medical Center
Career Start Year 2001
Number of shared co-authors 1
Patrick M A Sleiman
The Center for Applied Genomics, Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 42
Aaron D Gitler
Stanford University School of Medicine
Career Start Year 1999
Number of shared co-authors 19
Giovanni Coppola
David Geffen School of Medicine, University of California los angeles
Career Start Year 1999
Number of shared co-authors 41
Stephan Z??chner
Hussman Institute for Human Genomics, University of Miami
Career Start Year 1998
Number of shared co-authors 22
Joshua M Shulman
Baylor College of Medicine
Career Start Year 1998
Number of shared co-authors 49
Wuxing Yuan
Center for Cancer Research, National Cancer Institute
Career Start Year 1998
Number of shared co-authors 7
Suman Jayadev
University of Washington
Career Start Year 1995
Number of shared co-authors 54
Samuel M Goldman
University of California-San Francisco
Career Start Year 1994
Number of shared co-authors 13
William K Scott
John P. Hussman Institute for Human Genomics.
Career Start Year 1994
Number of shared co-authors 31
Andrea H N??meth
University of Oxford
Career Start Year 1993
Number of shared co-authors 5
Peter Hedera
University of Louisville
Career Start Year 1992
Number of shared co-authors 3
Giovanni Stevanin
Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS
Career Start Year 1992
Number of shared co-authors 11
Huw R Morris
Queen Square Institute of Neurology, University College London
Career Start Year 1991
Number of shared co-authors 51
Andrew A Hicks
Institute for Biomedicine, Affiliated institute of the University of Lubeck
Career Start Year 1990
Number of shared co-authors 15
Chang-En Yu
and Clinical Center
Career Start Year 1989
Number of shared co-authors 82
Dong-Hui Chen
University of Washington School of Medicine
Career Start Year 1988
Number of shared co-authors 1
Kirk C Wilhelmsen
West Virginia University
Career Start Year 1981
Number of shared co-authors 76
Guy A Rouleau
McGill University, Canada Montreal Neurological Institute and Hospital
Career Start Year 1981
Number of shared co-authors 47
James B Leverenz
Lou Ruvo Center for Brain Health, Cleveland Clinic
Career Start Year 1980
Number of shared co-authors 87
David G Standaert
University of Alabama at Birmingham
Career Start Year 1977
Number of shared co-authors 8
David J Burn
Population Health Sciences Institute, Newcastle University
Career Start Year 1975
Number of shared co-authors 27

Collaborators

Dennis W Dickson
Mayo Clinic Jacksonville
Co-authored papers 43
Nil??fer Ertekin-Taner
Mayo Clinic
Co-authored papers 26
Mariet Allen
Mayo Clinic
Co-authored papers 20
Minerva M Carrasquillo
Mayo Clinic
Co-authored papers 20
Thuy Nguyen
Mayo Clinic
Co-authored papers 20
Kimberly G Malphrus
Mayo Clinic Florida
Co-authored papers 19
Julia E Crook
Center for Clinical and Translational Science, Mayo Clinic
Co-authored papers 18
Neill R Graff-Radford
Mayo Clinic Florida
Co-authored papers 18
Ronald C Petersen
Mayo Clinic Rochester
Co-authored papers 14
Xue Wang
Mayo Clinic
Co-authored papers 12
Steven G Younkin
Mayo Clinic
Co-authored papers 12
Gina Bisceglio
Mayo Clinic
Co-authored papers 11
Curtis S Younkin
Mayo Clinic
Co-authored papers 10
Joseph S Reddy
Mayo Clinic
Co-authored papers 9
Yan W Asmann
Mayo Clinic
Co-authored papers 8
Walter A Rocca
Mayo Clinic
Co-authored papers 8
Timothy G Lesnick
Mayo Clinic
Co-authored papers 8
Jeremy D Burgess
Mayo Clinic
Co-authored papers 8
Mariza de Andrade
Mayo Clinic
Co-authored papers 7
Fanggeng Zou
Cincinnati Children's Hospital Medical Center
Co-authored papers 6
Daniel J Serie
Mayo Clinic
Co-authored papers 6
High Seng Chai
Mayo Clinic
Co-authored papers 5
Nicholas W Wood
UCL Queen Square Institute of Neurology
Co-authored papers 5
Henry Houlden
Institute of Neurology, University College London (UCL)
Co-authored papers 5
Bradley F Boeve
Mayo Clinic Rochester
Co-authored papers 5
Alison M Goate
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Todd E Golde
Emory Center for Neurodegenerative Disease
Co-authored papers 5
Nathan D Price
Institute for Systems Biology
Co-authored papers 5
Gerard D Schellenberg
Co-authored papers 5
Alexis Brice
Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS
Co-authored papers 4
Release 1.2